Page last updated: 2024-12-05

oxetane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Oxetane is a three-membered cyclic ether with the formula (CH2)3O. It is a colorless, flammable liquid with a sharp odor. Oxetane is a strained molecule due to the small ring size, which makes it reactive. It is used as a building block in organic synthesis and as a monomer in the production of polymers. Oxetane can be synthesized by several methods, including the ring-opening reaction of epoxides with aldehydes or ketones. The ring strain of oxetane makes it susceptible to ring-opening reactions, which can be used to introduce various functional groups into the molecule. Oxetane derivatives have been studied for their potential applications in medicine, agriculture, and materials science.'

oxetane: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

oxetane : A saturated organic heteromonocyclic parent that is a four-membered ring comprising of three carbon atoms and an oxygen atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10423
CHEMBL ID1538076
CHEBI ID30965
MeSH IDM0046734

Synonyms (51)

Synonym
BB 0261512
trimethylenoxid
nsc-30086
cyclooxabutane
oxacyclobutane
trimethylene oxide ,
wln: t4otj
503-30-0
1,3-propylene oxide
oxetane
.alpha.,.gamma.-propane oxide
1,3-epoxypropane
nsc30086
1,3-trimethylene oxide
CHEBI:30965 ,
inchi=1/c3h6o/c1-2-4-3-1/h1-3h
NCGC00090837-01
alpha,gamma-propane oxide
trimethylenoxid [german]
propane, 1,3-epoxy-
ai3-52868
einecs 207-964-3
hsdb 5492
oxetan
nsc 30086
ccris 4707
trimethylene oxide, 97%
AKOS005146196
FT-0658954
T0473
NCGC00090837-02
NCGC00258293-01
dtxsid8025969 ,
cas-503-30-0
tox21_200739
dtxcid705969
unii-i279q16fu6
i279q16fu6 ,
AM20020039
trimethylene oxide [mi]
1,3-epoxypropane [hsdb]
propylene oxide, 1,3-
trimethyleneoxide
Q-201891
CHEMBL1538076
trimethylene oxide, purum, >=97.0% (gc)
mfcd00005167
Q418107
D92348
25722-06-9
EN300-128688

Research Excerpts

Overview

Oxetane is a potential intermediate that is enzymatically formed during the repair of (6-4) DNA lesions. Oxetane has attractive properties such as low molecular weight, high polarity, and marked three-dimensionality.

ExcerptReferenceRelevance
"The oxetane ring is an emergent, underexplored motif in drug discovery that shows attractive properties such as low molecular weight, high polarity, and marked three-dimensionality. "( Oxetanes in Drug Discovery Campaigns.
Bull, JA; Rojas, JJ, 2023
)
2.91
"Oxetane is a potential intermediate that is enzymatically formed during the repair of (6-4) DNA lesions by special repair enzymes (6-4 DNA photolyases). "( Investigation of the pathways of excess electron transfer in DNA with flavin-donor and oxetane-acceptor modified DNA hairpins.
Breeger, S; Carell, T; Hennecke, U; von Meltzer, M, 2006
)
2

Effects

ExcerptReferenceRelevance
"Oxetanes have been shown to improve key properties when grafted onto molecular scaffolds."( Oxetanes as versatile elements in drug discovery and synthesis.
Burkhard, JA; Carreira, EM; Müller, K; Rogers-Evans, M; Wuitschik, G, 2010
)
2.52

Bioavailability

ExcerptReferenceRelevance
" While this lipophilic modification renders enhanced potency, the lipophilic tag(s) can diminish bioavailability and adversely alter drug transportation and metabolism."( Late-Stage Formal Double C-H Oxidation of Prenylated Molecules to Alkylidene Oxetanes and Azetidines by Strain-Enabled Cross-Metathesis.
Albitz, K; Csókás, D; Dobi, Z; Pápai, I; Soós, T, 2023
)
1.14
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
saturated organic heteromonocyclic parent
oxetanesAny oxacycle that is oxetane or its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency0.59520.000714.592883.7951AID1259369
thyroid stimulating hormone receptorHomo sapiens (human)Potency19.95260.001318.074339.8107AID926; AID938
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (159)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.26)18.7374
1990's1 (0.63)18.2507
2000's58 (36.48)29.6817
2010's75 (47.17)24.3611
2020's23 (14.47)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.41 (24.57)
Research Supply Index5.08 (2.92)
Research Growth Index6.41 (4.65)
Search Engine Demand Index76.15 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (5.03%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other151 (94.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]